Franklin Biotechnology Discovery Fund Class R6 (FRBRX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
123.82
+0.15 (0.12%)
Jun 18, 2025, 4:00 PM EDT
FRBRX Holdings List
As of May 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 8.17% |
2 | AMGN | Amgen Inc. | 7.64% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.25% |
4 | ASND | Ascendis Pharma A/S | 4.89% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 4.34% |
6 | ARGX | argenx SE | 3.80% |
7 | JAZZ | Jazz Pharmaceuticals plc | 3.79% |
8 | MRUS | Merus N.V. | 3.52% |
9 | PTCT | PTC Therapeutics, Inc. | 3.16% |
10 | NBIX | Neurocrine Biosciences, Inc. | 2.91% |
11 | BNTC | Benitec Biopharma Inc. | 2.77% |
12 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.74% |
13 | INSM | Insmed Incorporated | 2.34% |
14 | AZN | AstraZeneca PLC | 2.21% |
15 | GH | Guardant Health, Inc. | 1.94% |
16 | ARQT | Arcutis Biotherapeutics, Inc. | 1.86% |
17 | INFXX | Institutional Fiduciary Trust - Money Market Portfolio | 1.84% |
18 | LLY | Eli Lilly and Company | 1.53% |
19 | MLYS | Mineralys Therapeutics, Inc. | 1.49% |
20 | MIRM | Mirum Pharmaceuticals, Inc. | 1.41% |
21 | SPRY | ARS Pharmaceuticals, Inc. | 1.40% |
22 | CNTA | Centessa Pharmaceuticals plc | 1.36% |
23 | QURE | uniQure N.V. | 1.22% |
24 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.11% |
25 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.03% |
26 | PCVX | Vaxcyte, Inc. | 1.01% |
27 | BBIO | BridgeBio Pharma, Inc. | 0.88% |
28 | CGON | CG Oncology, Inc. | 0.85% |
29 | APGE | Apogee Therapeutics, Inc. | 0.84% |
30 | SNDX | Syndax Pharmaceuticals, Inc. | 0.84% |
31 | DAWN | Day One Biopharmaceuticals, Inc. | 0.80% |
32 | CTMX | CytomX Therapeutics, Inc. | 0.80% |
33 | AVTR | Avantor, Inc. | 0.73% |
34 | CPH: ZEAL | Zealand Pharma A/S | 0.72% |
35 | AURA | Aura Biosciences, Inc. | 0.71% |
36 | n/a | Benitec Biopharma ([Wts/Rts]) | 0.71% |
37 | JANX | Janux Therapeutics, Inc. | 0.66% |
38 | PRAX | Praxis Precision Medicines, Inc. | 0.65% |
39 | GPCR | Structure Therapeutics Inc. | 0.62% |
40 | NUVL | Nuvalent, Inc. | 0.62% |
41 | CGEM | Cullinan Therapeutics, Inc. | 0.62% |
42 | SYRE | Spyre Therapeutics, Inc. | 0.62% |
43 | OLMA | Olema Pharmaceuticals, Inc. | 0.60% |
44 | TMO | Thermo Fisher Scientific Inc. | 0.51% |
45 | DYN | Dyne Therapeutics, Inc. | 0.51% |
46 | RARE | Ultragenyx Pharmaceutical Inc. | 0.50% |
47 | OCUL | Ocular Therapeutix, Inc. | 0.49% |
48 | ORKA | Oruka Therapeutics, Inc. | 0.48% |
49 | ACHV | Achieve Life Sciences, Inc. | 0.47% |
50 | SRPT | Sarepta Therapeutics, Inc. | 0.46% |
51 | JBIO | Jade Biosciences, Inc. | 0.45% |
52 | ABVX | ABIVAX Société Anonyme | 0.44% |
53 | ORIC | ORIC Pharmaceuticals, Inc. | 0.44% |
54 | ANAB | AnaptysBio, Inc. | 0.42% |
55 | AKBA | Akebia Therapeutics, Inc. | 0.40% |
56 | XENE | Xenon Pharmaceuticals Inc. | 0.40% |
57 | COGT | Cogent Biosciences, Inc. | 0.39% |
58 | SION | Sionna Therapeutics, Inc. | 0.37% |
59 | EPA: DIM | Sartorius Stedim Biotech S.A. | 0.33% |
60 | ETR: SRT3 | Sartorius Aktiengesellschaft | 0.33% |
61 | MBX | MBX Biosciences, Inc. | 0.32% |
62 | CTNM | Contineum Therapeutics, Inc. | 0.32% |
63 | NAMS | NewAmsterdam Pharma Company N.V. | 0.27% |
64 | SLDB | Solid Biosciences Inc. | 0.27% |
65 | CYTK | Cytokinetics, Incorporated | 0.23% |
66 | ENGN | enGene Holdings Inc. | 0.20% |
67 | TERN | Terns Pharmaceuticals, Inc. | 0.19% |
68 | HLVX | HilleVax, Inc. | 0.19% |
69 | n/a | Lycia Therapeutics Inc Prf Usd 0.0001 Ser C | 0.18% |
70 | n/a | Candid Therapeutics Inc Cnv Pfd Ser B | 0.18% |
71 | KURA | Kura Oncology, Inc. | 0.17% |
72 | ANRO | Alto Neuroscience, Inc. | 0.16% |
73 | JSPR | Jasper Therapeutics, Inc. | 0.16% |
74 | SLNO | Soleno Therapeutics, Inc. | 0.15% |
75 | CNTX | Context Therapeutics Inc. | 0.13% |
76 | ABOS | Acumen Pharmaceuticals, Inc. | 0.12% |
77 | KYTX | Kyverna Therapeutics, Inc. | 0.09% |
78 | n/a | Achieve Life Sciences Inc Wts Exp 08/31/2027 *Vault* | 0.08% |
79 | TSX: MSCL | Satellos Bioscience Inc. | 0.08% |
80 | n/a | Carmot Therapeutics Inc Esrw Usd 1 | 0.06% |
81 | ARTV | Artiva Biotherapeutics, Inc. | 0.06% |
82 | INAB | IN8bio, Inc. | 0.05% |
83 | APLT | Applied Therapeutics, Inc. | 0.04% |
84 | n/a | In8bio Inc Series C Wts Exp 10/04/2027 *Not In Bank* | 0.01% |
85 | NUVB.WS | Nuvation Bio ([Wts/Rts]) | 0.00% |
86 | n/a | Dkk | 0.00% |
87 | n/a | Sanofi Sa Esrw Usd Npv Ref Sm# 1134484 | 0.00% |
88 | n/a | Usd | -0.08% |
As of May 31, 2025